David R. Wells
CIK 1480371 · Chief Financial Officer · last filed 2026-01-12
David R. Wells is a Chief Financial Officer who has filed 31 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for HSCSW, was dated Jan 12, 2026. Across all open-market trades the lifetime net is −$4.2K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
31
-$4.2K
Holdings By Company
Recent Filings
31 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-12 | HSCSW | Grant (A) | — | $0 | EDGAR |
| 2025-07-11 | HSCSW | Grant (A) | — | $0 | EDGAR |
| 2025-01-21 | HSCSW | Grant (A) | — | $0 | EDGAR |
| 2023-10-17 | COCHW | Grant (A) | — | $0 | EDGAR |
| 2023-03-22 | HSCSW | Grant (A) | — | $0 | EDGAR |
| 2021-04-07 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-06 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Sell (S) | −35,000 | -$31.5K | EDGAR |
| 2020-06-24 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Exer (X) | +5,000 | $4.3K | EDGAR |
| 2020-06-10 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Conv (C) | +10,350 | $9.0K | EDGAR |
| 2020-04-13 | ENDRA Life Sciences Inc. (NDRAW) Delisted | Grant (A) | +79,653 | $0 | EDGAR |